Gabapentin Premedication to Reduce Postoperative Pain for Pediatric Tonsillectomy
Children's Healthcare of Atlanta · NCT03625011
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 3–18 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- July 31, 2018
- Record last updated
- July 24, 2019
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this pilot study: 1) to examine the use of gabapentin in reducing pain in the first 48 hours postoperatively including the total amount of narcotics mg/kg given 2) to record the time to first analgesic postoperatively and 3) to compare Wong Baker and the 0-10 numeric pain distress scale scores at 12, 24 and 48 hours postoperatively. We hypothesize one 15mg/kg (up to 600mg) dose of gabapentin will decrease mean narcotic amounts in mg/kg compared to participants who do not receive preoperative gabapentin and will demonstrate a decreased mean time to first analgesic as well as to lower mean pain scores for each age group at 12, 24 and 48 hours.
Being studied: Gabapentin
Conditions: Tonsillitis; Tonsillectomy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- participants age 3-18 years
- ASA class 1 or 2
- elective Tonsillectomy/Adenoidectomy
- outpatient setting.
Exclusion Criteria
- BMI >40kg/m2
- history of renal insufficiency, chronic pain
- allergy to gabapentin
- history of developmental delay
Recruiting US locations
Children's Healthcare of Atlanta
Atlanta, GA 30329
Site contact: Beena Desai · 404-785-2269 · beena.desai@choa.org
Study contacts (from the official record)
- Beena Desai · 404-785-2269 · beena.desai@choa.org
- Margaret A Gettis, DNP,CPNP-PC · 404-785-8622 · margaret.gettis@choa.org
Similar studies in Georgia
All pain studies in Georgia →- RecruitingPhase 3
An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin
Adneuris Therapeutics, Inc.
- Location
- Savannah, GA + 14 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Decatur, GA + 57 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Eli Lilly and Company
- Location
- Decatur, GA + 37 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Eli Lilly and Company
- Location
- Woodstock, GA + 34 other US sites
- Eligibility basics
- Ages 18+